Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Nov;28(7):1017-25.
doi: 10.1007/s10571-008-9281-2. Epub 2008 Apr 19.

Enhanced 5-HT(2A) receptor status in the hypothalamus and corpus striatum of ethanol-treated rats

Affiliations

Enhanced 5-HT(2A) receptor status in the hypothalamus and corpus striatum of ethanol-treated rats

K G Akash et al. Cell Mol Neurobiol. 2008 Nov.

Abstract

Aim: Brain is the major target for the actions of ethanol and it can affect the brain in a variety of ways. In the present study we have investigated the changes in 5-HT level and the 5-HT(2A) receptors in the ethanol-treated rats.

Methods: Wistar adult male rats of 180-200 g body weight were given free access to 15% (v/v) (approx.7.5 g/Kg body wt./day) ethanol for 15 days. Controls were given free access to water for 15 days. Brain 5-HT and its metabolites were assayed by high performance liquid chromatography (HPLC) integrated with an electrochemical detector (ECD) fitted with C-18-CLS-ODS reverse phase column. 5-HT(2A) receptor binding assay was done with different concentrations of [3H] MDL 100907.

Results: The hypothalamic 5-HT content significantly increased (P < 0.001) with a decreased (P < 0.001) 5-HIAA/5-HT turnover in the ethanol-treated rats when compared to control. The corpus striatum 5-HT content significantly decreased (P < 0.01) with increased (P < 0.01) 5-HIAA/5- HT turnovers in the ethanol-treated rats when compared to control. Scatchard analysis of [(3)H] MDL 100907 against ketanserin in hypothalamus showed a significant increase (P < 0.001) in B(max )with a decreased affinity (P < 0.001) in ethanol-treated rats when compared to control. The competition curve for [3H] MDL 100907 against ketanserin fitted one-site model in all the groups with unity as Hill slope value. An increased K(i) and log (EC(50)) value were also observed in ethanol-treated rats when compared to control. Scatchard analysis of [3H] MDL 100907 against ketanserin in the corpus striatum of ethanol-treated rats showed a significant increase (P < 0.001) in B(max) and in affinity (P < 0.01) when compared to control. The change in affinity of the receptor protein in both corpus striatum and hypothalamus shows an altered receptor. The competition curve for [(3)H] MDL 100907 against ketanserin fitted one-site model in all the groups with unity as Hill slope value. There was no significant change in K(i) and log (EC (50)) value in ethanol-treated rats when compared to control.

Conclusion: The present study demonstrated the enhanced 5-HT(2A) receptor status in hypothalamus and corpus striatum. The ethanol-induced enhanced 5-HT(2A) receptors in the hypothalamus and corpus striatum has clinical significance in the better management of ethanol addiction. This will have therapeutic application.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Scatchard analysis of [3H] MDL 100907 against ketanserin in the hypothalamus of control- and ethanol-treated rats. Crude synaptic membrane preparation was suspended in 50 mM Tris HCl buffer pH 7.7 and used for assay. 0.25–2.0nM of [3H] MDL 100907 was incubated with and without excess of unlabelled ketanserin (100 mM). Tubes were incubated at 37 °C for 30 min and filtered rapidly through GF/B filters (Whatman). Bound radioactivity was determined with cocktail-T in a Wallac 1409 liquid scintillation counter. Specific binding was determined by subtracting non-specific binding from total binding
Fig. 2
Fig. 2
Displacement of [3H] MDL 100907 against ketanserin in the hypothalamus of control- and ethanol-treated rats. Competition studies were carried out with 0.5 nM [3H] MDL 100907 in each tube with the unlabelled ketanserin concentrations varying from 10–12 to 10–3 M. The tubes were incubated at 370 °C for 30 min and filtered rapidly through GF/B filters (Whatman). The filters were washed quickly by three successive washing with 3.0 ml of ice-cold buffer containing 50 mM Tris buffer, pH 7.7. Values are representation of 4–6 separate experiments
Fig. 3
Fig. 3
Scatchard analysis of [3H] MDL 100907 against ketanserin in the corpus striatum of control- and ethanol-treated rats. Crude synaptic membrane preparation was suspended in 50 mM Tris HCl buffer pH 7.7 and used for assay. 0.25–2.0nM of [3H] MDL 100907 was incubated with and without excess of unlabelled ketanserin (100 mM). Tubes were incubated at 37 °C for 30 min and filtered rapidly through GF/B filters (Whatman). Bound radioactivity was determined with cocktail-T in a Wallac 1409 liquid scintillation counter. Specific binding was determined by subtracting non-specific binding from total binding
Fig. 4
Fig. 4
Displacement of [3H] MDL 100907 against ketanserin in the corpus striatum of control- and ethanol-treated rats. Competition studies were carried out with 0.5 nM [3H] MDL 100907 in each tube with the unlabelled ketanserin concentrations varying from 10–12 to 10–3 M. The tubes were incubated at 370 °C for 30 min and filtered rapidly through GF/B filters (Whatman). The filters were washed quickly by three successive washing with 3.0 ml of ice-cold buffer containing 50 mM Tris buffer, pH 7.7. Values are representation of 4–6 separate experiments

References

    1. Ani DV, Savitha B, Paulose CS (2006) Decreased alpha1-adrenergic receptor binding in the cerebral cortex and brain stem during pancreatic regeneration in rats. J Neurosci Res 31:727–734 - PubMed
    1. Badawy AA, Morgan CJ, Lovett JW, Bradley DM, Thomas R (1995) Decrease in circulating tryptophan availability to the brain after acute ethanol consumption by normal volunteers: implications for alcohol-induced aggressive behaviour and depression. Pharmacopsychiatry 28:93–97 - PubMed
    1. Bavanisha V, Charmaine HJ, Stefan M, Willie, P, Dan JS (2005) Pharmacological challenge with a serotonin 1D agonist in alcohol dependence. BMC Psychiatry 5:31–34 - PMC - PubMed
    1. Benkelfat C, Murphy DL, Hill JL, George DT, Nutt D, Linnoila M (1991) Ethanol- like properties of the serotonergic partial agonist mchlorophenylpiperazine in chronic alcoholic patients. Arch Gen Psychiatry 48:333–336 - PubMed
    1. Berke JD, Hyman SE (2000) Addiction, dopamine, and the molecular mechanisms of memory. Neuron 25:515–532 - PubMed

Publication types

MeSH terms

LinkOut - more resources